ATE159547T1 - Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus - Google Patents

Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus

Info

Publication number
ATE159547T1
ATE159547T1 AT92907669T AT92907669T ATE159547T1 AT E159547 T1 ATE159547 T1 AT E159547T1 AT 92907669 T AT92907669 T AT 92907669T AT 92907669 T AT92907669 T AT 92907669T AT E159547 T1 ATE159547 T1 AT E159547T1
Authority
AT
Austria
Prior art keywords
ppv
vaccine against
capsides
subunicial
producing
Prior art date
Application number
AT92907669T
Other languages
English (en)
Inventor
Alvarez Jose Ignacio Casal
Valdes Elena Cortes
Casares Ana Isabel Ranz
Olmo Carmen Vela
Kristian Dalsgaard
Original Assignee
Inmunologia & Genetica Aplic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inmunologia & Genetica Aplic filed Critical Inmunologia & Genetica Aplic
Application granted granted Critical
Publication of ATE159547T1 publication Critical patent/ATE159547T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92907669T 1991-03-26 1992-03-26 Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus ATE159547T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9100845A ES2026827A6 (es) 1991-03-26 1991-03-26 Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.

Publications (1)

Publication Number Publication Date
ATE159547T1 true ATE159547T1 (de) 1997-11-15

Family

ID=8271931

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907669T ATE159547T1 (de) 1991-03-26 1992-03-26 Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus

Country Status (8)

Country Link
US (1) US5498413A (de)
EP (1) EP0551449B1 (de)
AT (1) ATE159547T1 (de)
AU (1) AU1537792A (de)
DE (1) DE69222840T2 (de)
DK (1) DK0551449T3 (de)
ES (1) ES2026827A6 (de)
WO (1) WO1992017589A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001833A1 (en) * 1991-07-17 1993-02-04 Commonwealth Scientific And Industrial Research Organisation Improved vaccine
DE69415462T2 (de) * 1993-01-23 1999-07-15 Inmunologia Y Genetica Aplicada, S.A., Madrid Synthetischen peptiden und impfstoffe gegen parvovirus
ES2080023B1 (es) * 1994-07-08 1996-08-16 Iberica Cyanamid Capsidas y proteinas recombinantes del virus de la enfermedad hemorragica del conejo (rhdv), kits de diagnostico y vacunas que contienen dichos productos recombinantes.
WO1997040163A1 (en) * 1996-04-19 1997-10-30 Metin Colpan Nucleic acid vaccination for parvoviral infections
CA2223029A1 (en) * 1997-02-12 1998-08-12 Akzo Nobel Nv Canine parvovirus dna vaccines
US7192594B2 (en) * 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
RU2000118777A (ru) * 1997-12-11 2002-07-10 Университи Оф Саскачеван (Ca) Вирус синдрома мультисистемного истощения свиньи у поросят-отъемышей
BR9804283B1 (pt) * 1998-03-18 2010-11-30 processo para a produção de flavivìrus em baixa densidade de células em cultura e processo para a produção de flavivìrus recombinante em baixa densidade de células em cultura.
ES2139537B1 (es) * 1998-03-24 2000-10-01 Inmunologia & Genetica Aplic Sistema de presentacion de antigenos basado en el virus de la sharka.
US6238860B1 (en) 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
SE516522C2 (sv) 1999-05-28 2002-01-22 Anoto Ab Positionsbestämning
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
CA2373110A1 (en) * 2000-03-14 2001-09-20 Neurologix, Inc. Production of chimeric capsid vectors
DE60125170T2 (de) * 2000-06-05 2008-01-24 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food In pflanzen erzeugte rekombinante proteinuntereinheit eines parvovirus vom schwein
JP5394750B2 (ja) * 2005-12-29 2014-01-22 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド 多価ｐｃｖ２免疫原性組成物及び当該組成物を製造する方法
CN101851609B (zh) * 2010-02-02 2012-10-03 哈药集团生物疫苗有限公司 猪细小病毒l株及在制备猪细小病毒病灭活疫苗中的用途
BR112016006192A2 (pt) 2013-09-25 2017-09-26 Zoetis Services Llc composição de vacina de divergente de pcv2b e métodos de uso
CA3042584A1 (en) * 2016-11-03 2018-05-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof
BR112019009133A2 (pt) 2016-11-03 2019-07-16 Boehringer Ingelheim Vetmedica Gmbh vacina contra o parvovírus suíno
KR102117811B1 (ko) 2018-12-05 2020-06-02 대한민국(농림축산식품부 농림축산검역본부장) 재조합 돼지파보바이러스 항원 단백질 및 이의 용도
EP3953370A1 (de) 2019-04-04 2022-02-16 Boehringer Ingelheim Animal Health USA Inc. Impfstoffe gegen das porcine circovirus typ 3 (pcv3), ihre herstellung und verwendung
CN110845580A (zh) * 2019-11-05 2020-02-28 中国农业科学院兰州兽医研究所 一种猪细小病毒样颗粒的组装及其免疫原性鉴定方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0117767A1 (de) * 1983-01-07 1984-09-05 Mgi Pharma, Inc. Herstellung von Untereinheiten von Parvovirus-Vakzinen
WO1988002026A1 (en) * 1986-09-08 1988-03-24 Applied Biotechnology, Inc. Empty viral capsid vaccines
US4971793A (en) * 1988-05-09 1990-11-20 Boyce Thompson Institute For Plant Research, Inc. Subunit canine parvovirus vaccine
DD286820A5 (de) * 1989-08-10 1991-02-07 Univ Berlin Humboldt Verfahren zur herstellung des rekombinanten proteins hbcag delta-hivp24, das eine fusion aus den coreproteinen von hepatitis b-virus und humahem immundefizienzvirus 1 darstellt

Also Published As

Publication number Publication date
US5498413A (en) 1996-03-12
AU1537792A (en) 1992-11-02
WO1992017589A1 (es) 1992-10-15
EP0551449B1 (de) 1997-10-22
DK0551449T3 (da) 1998-07-20
DE69222840D1 (de) 1997-11-27
EP0551449A1 (de) 1993-07-21
ES2026827A6 (es) 1992-05-01
DE69222840T2 (de) 1998-05-14

Similar Documents

Publication Publication Date Title
ATE159547T1 (de) Verfahren zur herstellung von untereinheisimpfstoff gegen schweinparvovirus
ATE161729T1 (de) Verfahren zur herstellung von untereinheitsimpfstoff gegen hundeparvovirus und verwandten viren
Vakharia et al. Molecular basis of antigenic variation in infectious bursal disease virus
Dertzbaugh Genetically engineered vaccines: an overview
DK157087D0 (da) Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus
Kibenge et al. Genome cloning and analysis of the large RNA segment (segment A) of a naturally avirulent serotype 2 infectious bursal disease virus
KR920703831A (ko) 백신(vaccines)
EP1033995A4 (de) Insektenzellen oder fraktionen als antigenadjuvanz
ATE302795T1 (de) Sich selbst-zusammenbauende rekombinante hpv16 papillomavirus hüllproteine
DE69533690D1 (de) Recombinante prrs viren -proteine und dieselben diagnosesätze und impfstoffe enthaltenden
EP1298139A3 (de) Auf Herpesvirus gegründeter rekombinanter Impfstoff gegen die infektiöse Bursalkrankheit
MX2010000235A (es) Virus del sindrome respiratorio y reproductivo porcino tipo 1 norteamericano recombinante y metodos de uso.
Chen et al. A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine
Thomas et al. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus
MXPA01008966A (es) Vacunas contra el virus sincicial respiratorio a base de acido nucleico.
WO1998055626A3 (en) Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
DE68920610D1 (de) Rekombinantes Virus der Marekschen Krankheit und Vakzin.
Fahey et al. A recombinant subunit vaccine that protects progeny chickens from infectious bursal disease
JP2009544303A5 (de)
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
Vakharia Development of recombinant vaccines against infectious bursal disease
RU2006106427A (ru) Вакцина
ATE126274T1 (de) Rekombinanter impfstoff gegen marek's krankheit.
Grigera et al. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee